Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Queensland Health
Accenture
Fish and Richardson
Mallinckrodt
Johnson and Johnson

Generated: July 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,268,791

Try a free trialSee Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,268,791 protect, and when does it expire?

Patent 8,268,791 protects TOSYMRA and is included in one NDA.

This patent has twenty-nine patent family members in thirteen countries.

Summary for Patent: 8,268,791
Title:Alkylglycoside compositions for drug administration
Abstract: The present invention provides compositions and methods and for increasing the bioavailability of therapeutic agents in a subject. The compositions include at least one alkyl glycoside and at least one therapeutic agent, wherein the alkylglycoside has an alkyl chain length from about 10 to about 16 carbon atoms.
Inventor(s): Maggio; Edward T. (San Diego, CA)
Assignee: Aegis Therapeutics, LLC. (San Diego, CA)
Application Number:12/341,696
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 8,268,791
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 8,268,791

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Dr Reddys Labs Ltd TOSYMRA sumatriptan SPRAY;NASAL 210884-001 Jan 25, 2019 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 8,268,791

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2009329952 ➤ Try a Free Trial
Australia 2011317202 ➤ Try a Free Trial
Canada 2748268 ➤ Try a Free Trial
Canada 2814927 ➤ Try a Free Trial
China 102325450 ➤ Try a Free Trial
China 103189068 ➤ Try a Free Trial
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKinsey
Baxter
US Department of Justice
Accenture
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.